Aluminum accumulation in children on chronic dialysis: predictive value of serum aluminum levels and desferrioxamine infusion test. 1987

A M Roodhooft, and F L van de Vyver, and P C D'Haese, and K J van Acker, and W J Visser, and M E de Broe
Department of Pediatrics, University of Antwerp, Belgium.

In 7 children on chronic dialysis the correlation between serum aluminum, aluminum after desferrioxamine (DFO) challenge and bone aluminum was studied. In children the DFO challenge test is not superior to the serum aluminum level for the estimation of aluminum body burden. A significant correlation between serum aluminum and bone aluminum content was found. In all children, except one, aluminum bone content was markedly elevated.

UI MeSH Term Description Entries
D007676 Kidney Failure, Chronic The end-stage of CHRONIC RENAL INSUFFICIENCY. It is characterized by the severe irreversible kidney damage (as measured by the level of PROTEINURIA) and the reduction in GLOMERULAR FILTRATION RATE to less than 15 ml per min (Kidney Foundation: Kidney Disease Outcome Quality Initiative, 2002). These patients generally require HEMODIALYSIS or KIDNEY TRANSPLANTATION. ESRD,End-Stage Renal Disease,Renal Disease, End-Stage,Renal Failure, Chronic,Renal Failure, End-Stage,Chronic Kidney Failure,End-Stage Kidney Disease,Chronic Renal Failure,Disease, End-Stage Kidney,Disease, End-Stage Renal,End Stage Kidney Disease,End Stage Renal Disease,End-Stage Renal Failure,Kidney Disease, End-Stage,Renal Disease, End Stage,Renal Failure, End Stage
D008297 Male Males
D010530 Peritoneal Dialysis Dialysis fluid being introduced into and removed from the peritoneal cavity as either a continuous or an intermittent procedure. Dialyses, Peritoneal,Dialysis, Peritoneal,Peritoneal Dialyses
D001842 Bone and Bones A specialized CONNECTIVE TISSUE that is the main constituent of the SKELETON. The principal cellular component of bone is comprised of OSTEOBLASTS; OSTEOCYTES; and OSTEOCLASTS, while FIBRILLAR COLLAGENS and hydroxyapatite crystals form the BONE MATRIX. Bone Tissue,Bone and Bone,Bone,Bones,Bones and Bone,Bones and Bone Tissue,Bony Apophyses,Bony Apophysis,Condyle,Apophyses, Bony,Apophysis, Bony,Bone Tissues,Condyles,Tissue, Bone,Tissues, Bone
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D003676 Deferoxamine Natural product isolated from Streptomyces pilosus. It forms iron complexes and is used as a chelating agent, particularly in the mesylate form. Desferrioxamine,Deferoxamine B,Deferoxamine Mesilate,Deferoxamine Mesylate,Deferoxamine Methanesulfonate,Deferoximine,Deferrioxamine B,Desferal,Desferioximine,Desferrioxamine B,Desferrioxamine B Mesylate,Desferroxamine,Mesilate, Deferoxamine,Mesylate, Deferoxamine,Mesylate, Desferrioxamine B,Methanesulfonate, Deferoxamine
D005260 Female Females
D006435 Renal Dialysis Therapy for the insufficient cleansing of the BLOOD by the kidneys based on dialysis and including hemodialysis, PERITONEAL DIALYSIS, and HEMODIAFILTRATION. Dialysis, Extracorporeal,Dialysis, Renal,Extracorporeal Dialysis,Hemodialysis,Dialyses, Extracorporeal,Dialyses, Renal,Extracorporeal Dialyses,Hemodialyses,Renal Dialyses
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

A M Roodhooft, and F L van de Vyver, and P C D'Haese, and K J van Acker, and W J Visser, and M E de Broe
January 1985, Nephron,
A M Roodhooft, and F L van de Vyver, and P C D'Haese, and K J van Acker, and W J Visser, and M E de Broe
February 1986, Kidney international. Supplement,
A M Roodhooft, and F L van de Vyver, and P C D'Haese, and K J van Acker, and W J Visser, and M E de Broe
January 1986, ASAIO transactions,
A M Roodhooft, and F L van de Vyver, and P C D'Haese, and K J van Acker, and W J Visser, and M E de Broe
October 1995, American journal of kidney diseases : the official journal of the National Kidney Foundation,
A M Roodhooft, and F L van de Vyver, and P C D'Haese, and K J van Acker, and W J Visser, and M E de Broe
March 1984, The International journal of artificial organs,
A M Roodhooft, and F L van de Vyver, and P C D'Haese, and K J van Acker, and W J Visser, and M E de Broe
January 1982, Nephron,
A M Roodhooft, and F L van de Vyver, and P C D'Haese, and K J van Acker, and W J Visser, and M E de Broe
January 1988, ASAIO transactions,
A M Roodhooft, and F L van de Vyver, and P C D'Haese, and K J van Acker, and W J Visser, and M E de Broe
June 1984, Research communications in chemical pathology and pharmacology,
A M Roodhooft, and F L van de Vyver, and P C D'Haese, and K J van Acker, and W J Visser, and M E de Broe
January 1989, Annali dell'Istituto superiore di sanita,
A M Roodhooft, and F L van de Vyver, and P C D'Haese, and K J van Acker, and W J Visser, and M E de Broe
November 1984, The Journal of pediatrics,
Copied contents to your clipboard!